Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 2.53%128.27B | 7.61%614.63B | 12.94%125.11B | 1.40%571.19B | -8.73%187.43B | 9.29%138.86B | 8.69%134.12B | 3.07%110.77B | -4.37%563.3B | 3.12%205.37B |
| Cost of revenue | 2.13%110.93B | 7.05%530.39B | 12.12%108.62B | 0.35%495.47B | -9.72%161.98B | 7.99%119.69B | 7.45%116.93B | 2.32%96.87B | -3.30%493.75B | 2.83%179.42B |
| Gross profit | 5.11%17.34B | 11.27%84.24B | 18.67%16.49B | 8.87%75.71B | -1.90%25.45B | 18.12%19.17B | 17.91%17.19B | 8.68%13.9B | -11.33%69.54B | 5.13%25.94B |
| Operating expense | 3.24%9.7B | 4.80%38.24B | 1.56%9.39B | -2.52%36.49B | -2.62%10.52B | 3.54%9.05B | -11.42%7.68B | 0.21%9.25B | 5.56%37.44B | 12.68%10.81B |
| Operating profit | 7.58%7.64B | 17.28%46B | 52.70%7.1B | 22.16%39.22B | -1.38%14.93B | 35.12%10.13B | 60.91%9.52B | 30.65%4.65B | -25.27%32.11B | 0.32%15.14B |
| Net non-operating interest income (expenses) | -33.33%-4M | 700.00%6M | -3M | 66.67%-1M | -2M | -200.00%-1M | 300.00%2M | 0 | 62.50%-3M | 0 |
| Non-operating interest income | 0.00%2M | 78.95%34M | -50.00%2M | -17.39%19M | -20.00%4M | -42.86%4M | 16.67%7M | -20.00%4M | 0.00%23M | -16.67%5M |
| Non-operating interest expense | 20.00%6M | 40.00%28M | 25.00%5M | -23.08%20M | 20.00%6M | -16.67%5M | -28.57%5M | -50.00%4M | -16.13%26M | -61.54%5M |
| Net investment income | 8.48%537M | 3.50%858M | 10.00%495M | -2.47%829M | 933.33%31M | 11.99%327M | -8.70%21M | -15.41%450M | 0.24%850M | -62.50%3M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 10,100.00%510M | 181.05%267M | -16.67%5M | 246.15%95M | 182.02%73M | 0 | 16M | -66.67%6M | -116.17%-65M | -9,000.00%-89M |
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 101.53%4M | -717.60%-2.42B | -137.27%-261M | 114.40%392M | 79.17%-528M | 599.48%969M | 149.59%61M | -185.27%-110M | -186.33%-2.72B | -590.74%-2.54B |
| Less:Restructuring and mergern&acquisition | --0 | -24.91%205M | 361.54%60M | 237.04%273M | ---- | ---- | 187.50%46M | -74.51%13M | -10.00%81M | ---- |
| Less:Other special charges | -101.99%-4M | 205.76%1.03B | 107.22%201M | -765.75%-972M | -23.81%-52M | -415.33%-823M | -281.31%-194M | 153.89%97M | -80.35%146M | -117.43%-42M |
| Less:Write off | ---- | 286.97%1.19B | ---- | -87.70%307M | ---- | ---- | ---- | ---- | 2,015.25%2.5B | ---- |
| Other non-operating income (expenses) | -3.70%130M | 3.36%461M | -1.46%135M | 17.06%446M | 113.21%113M | -38.89%88M | 414.29%108M | -15.95%137M | 64.22%381M | 226.19%53M |
| Income before tax | 18.02%8.82B | 10.21%45.17B | 45.53%7.47B | 34.19%40.98B | 16.33%14.62B | 48.68%11.51B | 66.64%9.73B | 16.66%5.13B | -29.76%30.54B | -14.41%12.57B |
| Income tax | 14.75%2.9B | 8.14%14.21B | 33.76%2.53B | 20.31%13.14B | -0.29%4.49B | 29.06%3.42B | 64.28%3.34B | 8.81%1.89B | -22.29%10.93B | 2.72%4.5B |
| Net income | 19.67%5.91B | 11.19%30.95B | 52.39%4.94B | 41.92%27.84B | 25.60%10.13B | 58.95%8.08B | 67.88%6.38B | 21.78%3.24B | -33.34%19.62B | -21.70%8.07B |
| Net income continuous operations | 19.69%5.92B | 11.19%30.95B | 52.39%4.94B | 41.92%27.84B | 25.60%10.13B | 58.91%8.08B | 67.90%6.38B | 21.78%3.24B | -33.34%19.62B | -21.69%8.07B |
| Noncontrolling interests | -66.94%120M | 127.53%876M | 4,437.50%363M | 39.49%385M | -50.40%185M | 548.00%112M | 286.05%80M | 127.59%8M | 26.61%276M | 168.35%373M |
| Net income attributable to the company | 26.54%5.79B | 9.55%30.08B | 41.56%4.58B | 41.96%27.45B | 29.34%9.95B | 55.96%7.97B | 63.90%6.3B | 20.13%3.23B | -33.79%19.34B | -24.33%7.69B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 26.54%5.79B | 9.55%30.08B | 41.56%4.58B | 41.96%27.45B | 29.34%9.95B | 55.96%7.97B | 63.90%6.3B | 20.13%3.23B | -33.79%19.34B | -24.33%7.69B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 28.57%49.32 | 10.97%253.54 | 43.13%38.36 | 43.85%228.47 | 30.94%82.99 | 57.95%66.34 | 66.58%52.34 | 21.65%26.8 | -32.56%158.83 | -23.09%63.38 |
| Diluted earnings per share | 28.65%49.22 | 10.90%253.01 | 42.87%38.26 | 43.75%228.15 | 30.78%82.82 | 57.87%66.26 | 66.53%52.29 | 21.67%26.78 | -32.52%158.71 | -23.08%63.33 |
| Dividend per share | 0 | 9.52%115 | 0 | 5.00%105 | 10.00%55 | 0 | 0.00%50 | 0 | 5.26%100 | 0.00%50 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |